|
Market Closed -
Nasdaq
23:00:00 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 250.69 USD | -1.24% |
|
+7.75% | +42.45% |
| 10-22 | BofA Securities Adjusts Biogen Price Target to $244 From $219 | MT |
| 10-21 | TD Cowen Adjusts Price Target on Biogen to $250 From $225 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOGEN INC. | Biopharmaceuticals | -1.24% | +7.75% | +42.45% | +67.25% | -5.33% | 37.04B |  | | |
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
